Factors Associated with the Refusal of Direct-Acting Antiviral Agents for the Treatment of Hepatitis C in Taiwan

Background and Objectives: Direct-acting antiviral agents (DAA) are a safe and highly effective treatment for hepatitis C virus (HCV) infection. However, the uptake of DAA treatment remains a challenge. This study aims to examine the reasons for DAA refusal among HCV patients covered by the Taiwan N...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Li-Jen, Chang, Han-Cheng, Chen, Po-Yueh, Chen, Chi-Yi, Tsai, Kun-Feng, Yean, Koh-Kok, Yang, Hsin-Yi, Chen, Tsung-Hsien, Yu, Pao-Ta, Chou, Chu-Kuang, Chen, Sheng-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031294/
https://www.ncbi.nlm.nih.gov/pubmed/35454360
http://dx.doi.org/10.3390/medicina58040521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031294/
https://www.ncbi.nlm.nih.gov/pubmed/35454360
http://dx.doi.org/10.3390/medicina58040521

Ejemplares similares